v3.26.3
SCHEDULE OF NUMBER OF OPTIONS GRANTED (Details) (Parenthetical) - Stock Option Plan [Member] - USD ($)
 9 Months Ended 12 Months Ended
Feb. 01, 2026
Aug. 01, 2025
Apr. 30, 2026
Jul. 31, 2026
Jul. 31, 2025
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Number of options granted 291,000 37,700   328,700 [1] 333 [1]
Weighted average exercise price, granted $ 5.59 $ 12.50   $ 6.38 [1],[2] $ 60.00 [1],[2]
Options vest periods 2 years 2 years      
options expire date Feb. 01, 2031 Aug. 01, 2030      
Number of options issued $ 1,031,192 $ 218,784      
Expected volatility 123.00%     116.00% 112.00%
Expected term 5 years     5 years 5 years
Risk free interest rate 3.79%     3.98% 4.45%
Dividend yield 0.00%   0.00% 0.00% 0.00%
Exercise price $ 4.30     $ 7.50  
Unrecognized costs       $ 3,449,165  
Employee Stock [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Weighted-average grant date per-share       $ 3.80 $ 48.77
[1] On August 1, 2025, the Company granted 37,700 stock options to employees and members of the scientific advisory board at an exercise price of $12.50 per share. All options vest quarterly over two years. The options expire on August 1, 2030. The grant-date fair value of the award was $218,784. The fair value of options granted on August 1, 2025 was estimated using the Black-Scholes option-pricing model with the following weighted-average assumptions: expected volatility of 116%, expected term of 5.0 years, risk-free interest rate of 3.98%, dividend yield of 0%, and a stock price of $7.50 on the grant date.
[2] certain options are exercisable in Canadian dollars and translated to US Dollars at year end.